SupplementaryTables S7-S16 from Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
<p>Supplementary Table S7-S16</p>
Publications
5 shownPhase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3
Purpose This phase III study evaluated ribociclib plus fulvestrant in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast c...
Supplementary Methods from Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
<p>Supplementary Methods</p>
Supplementary Figures from Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
<p>Supplementary Figures</p>
Supplementary Tables S1-S6, S17-S18 from Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
<p>Supplementary Tables S1-S6_S17-S18</p>
Frequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 5
- Citations
- 1,036
- Institution
- Centre Hospitalier Universitaire de Liège
External Links
Identifiers
- ORCID
- 0000-0003-3630-4527
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.